Digestive Surgery Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, 8, 00166, Rome, Italy.
Università Cattolica del Sacro Cuore Di Roma, Rome, Italy.
Surg Endosc. 2021 Jun;35(6):2592-2600. doi: 10.1007/s00464-020-07677-3. Epub 2020 Jun 1.
Despite the comparable results between ESD and gastrectomy reported in multiple Asiatic studies, limited data are currently present on the long-term efficacy of ESD for EGC in Western countries. The aim of this study was to compare the short- and long-term outcomes of the endoscopic submucosal dissection and surgery for non-diffuse early gastric cancer treatment in a Western cohort of patients.
All patients with a diagnosis of intestinal type EGC located in the middle and lower third of the stomach from 2005 to 2015 were enrolled in the study. All patients completed a 5-year follow-up. Patients were divided according to the procedure performed (ESD/subtotal gastrectomy). The two groups were matched for age, gender, ASA score, tumor dimension, and grade of infiltration (mucosa/submucosa).
After matching, 84 patients (42 per group) were included in the analysis. Peri-procedural morbidity rate was 7.1% and no difference was observed between the two groups (4.8% vs 9.5% for ESD and STG groups, respectively; p = 0.3). Similar results in terms of 5-year OS and DFS were observed for ESD and STG (77.7% vs 71.8% ; p = 0.78 and 74.9% vs 72% ; p = 0.7, respectively). At the multivariate analysis, ASA3 score was recognized as the only negative predictor factor for the 5-year OS (OR 6.2; 95% CI 2.2-16.8; p < 0.001). Regarding the DFS, both ASA3 score (OR 4.4; 95% CI 1.7-10.9; p < 0.001) and submucosal infiltration(OR 5.1; 95% CI 1.2-22.4 ; p = 0.02) were identified as independent risk factors for a worse outcome.
Our results confirm the safety and feasibility ESD for EGC treatment in a Western setting. In addition, this is one of the few reports showing comparable results both in terms of short- and long-term outcomes between ESD and surgery for intestinal type ECG treatment in Western countries.
尽管多项亚洲研究报告 ESD 和胃切除术的结果相当,但目前关于 ESD 治疗西方国家非弥漫性早期胃癌的长期疗效的数据有限。本研究的目的是比较内镜黏膜下剥离术和手术治疗西方患者非弥漫性早期胃癌的短期和长期结果。
本研究纳入了 2005 年至 2015 年间诊断为位于胃中下部的肠型 EGC 的所有患者。所有患者均完成了 5 年随访。根据所进行的操作(ESD/胃大部切除术)将患者分为两组。两组患者的年龄、性别、ASA 评分、肿瘤大小和浸润程度(黏膜/黏膜下)相匹配。
匹配后,84 例患者(每组 42 例)纳入分析。围手术期发病率为 7.1%,两组间无差异(ESD 组和 STG 组分别为 4.8%和 9.5%;p=0.3)。ESD 和 STG 的 5 年 OS 和 DFS 结果相似(ESD 组和 STG 组分别为 77.7%和 71.8%;p=0.78 和 74.9%和 72%;p=0.7)。多因素分析显示,ASA3 评分是 5 年 OS 的唯一负预测因素(OR 6.2;95%CI 2.2-16.8;p<0.001)。对于 DFS,ASA3 评分(OR 4.4;95%CI 1.7-10.9;p<0.001)和黏膜下浸润(OR 5.1;95%CI 1.2-22.4;p=0.02)均为较差结局的独立危险因素。
我们的结果证实了 ESD 治疗西方 EGC 的安全性和可行性。此外,这是为数不多的报告之一,表明在西方国家,肠型 ECG 治疗中 ESD 和手术的短期和长期结果相当。